IS2477B - Aðferð til að framleiða díoxanediksýruestera - Google Patents

Aðferð til að framleiða díoxanediksýruestera

Info

Publication number
IS2477B
IS2477B IS7617A IS7617A IS2477B IS 2477 B IS2477 B IS 2477B IS 7617 A IS7617 A IS 7617A IS 7617 A IS7617 A IS 7617A IS 2477 B IS2477 B IS 2477B
Authority
IS
Iceland
Prior art keywords
group
acetic acid
acid esters
formula
acid chloride
Prior art date
Application number
IS7617A
Other languages
English (en)
Other versions
IS7617A (is
Inventor
Carolus Catherina Karel Bakel Van Hermanus
Monique Charles Callant Dominique
Hermanus Mattheus Hero Kooistra Jacob
Johannes Dominicus Maas Peter
Original Assignee
Astrazeneca Uk Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Uk Limited filed Critical Astrazeneca Uk Limited
Publication of IS7617A publication Critical patent/IS7617A/is
Publication of IS2477B publication Critical patent/IS2477B/is

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/06—1,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Steroid Compounds (AREA)
IS7617A 2002-06-17 2004-12-28 Aðferð til að framleiða díoxanediksýruestera IS2477B (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02100715A EP1375493A1 (en) 2002-06-17 2002-06-17 Process for the preparation of an dioxane acetic acid ester
PCT/NL2003/000435 WO2003106447A1 (en) 2002-06-17 2003-06-12 Process for the preparation of dioxane acetic acid esters

Publications (2)

Publication Number Publication Date
IS7617A IS7617A (is) 2004-12-28
IS2477B true IS2477B (is) 2008-12-15

Family

ID=29716908

Family Applications (1)

Application Number Title Priority Date Filing Date
IS7617A IS2477B (is) 2002-06-17 2004-12-28 Aðferð til að framleiða díoxanediksýruestera

Country Status (27)

Country Link
US (1) US7442811B2 (is)
EP (2) EP1375493A1 (is)
JP (1) JP4632784B2 (is)
KR (1) KR101008920B1 (is)
CN (2) CN101812045B (is)
AT (1) ATE348825T1 (is)
AU (1) AU2003277230B2 (is)
BR (1) BR0311884A (is)
CA (1) CA2490205C (is)
CY (1) CY1107344T1 (is)
DE (1) DE60310559T2 (is)
DK (1) DK1515962T3 (is)
EG (1) EG24561A (is)
ES (1) ES2278174T3 (is)
HK (1) HK1073303A1 (is)
IL (1) IL165767A0 (is)
IS (1) IS2477B (is)
MX (1) MXPA04012651A (is)
NO (1) NO328946B1 (is)
NZ (1) NZ537260A (is)
PL (1) PL207130B1 (is)
PT (1) PT1515962E (is)
RU (1) RU2315761C2 (is)
SI (1) SI1515962T1 (is)
UA (1) UA79970C2 (is)
WO (1) WO2003106447A1 (is)
ZA (1) ZA200409986B (is)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0011120D0 (en) 2000-05-09 2000-06-28 Avecia Ltd Process
NL1015744C2 (nl) * 2000-07-19 2002-01-22 Dsm Nv Werkwijze voor de bereiding van 2-(6-gesubstitueerde-1,3-dioxan-4-yl) azijnzuurderivaten.
AR034772A1 (es) 2001-07-13 2004-03-17 Astrazeneca Uk Ltd Preparacion de los compuestos de aminopirimidina
EP1323717A1 (en) 2001-12-27 2003-07-02 Dsm N.V. Process for the preparation of 2-(6-Substituted-1,3-Dioxane-4-yL) acetic acid derivatives
GB0218781D0 (en) 2002-08-13 2002-09-18 Astrazeneca Ab Chemical process
KR101060215B1 (ko) 2002-12-16 2011-08-29 아스트라제네카 유케이 리미티드 피리미딘 화합물의 제조 방법
GB0312896D0 (en) 2003-06-05 2003-07-09 Astrazeneca Ab Chemical process
UY28501A1 (es) 2003-09-10 2005-04-29 Astrazeneca Uk Ltd Compuestos químicos
GB0324791D0 (en) * 2003-10-24 2003-11-26 Astrazeneca Ab Chemical process
GB0428328D0 (en) 2004-12-24 2005-02-02 Astrazeneca Uk Ltd Chemical process
GB0514078D0 (en) * 2005-07-08 2005-08-17 Astrazeneca Uk Ltd Chemical process
TW200831469A (en) * 2006-12-01 2008-08-01 Astrazeneca Uk Ltd Chemical process
GB2482525A (en) * 2010-08-05 2012-02-08 Phoenix Chemicals Ltd A process for the production of acyloxymethyldioxanylacetic derivatives
CN105198856B (zh) * 2014-06-27 2017-10-13 上海弈柯莱生物医药科技有限公司 一种2‑(6‑取代1,3‑二噁烷‑4‑基)乙酸衍生物的制备方法
RU2596623C1 (ru) * 2015-07-20 2016-09-10 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Уфимский государственный нефтяной технический университет" Способ получения 1,4-диоксанкарбоксилатов
CN111675689B (zh) * 2020-06-16 2021-08-24 浙江工业大学 一种瑞舒伐他汀中间体的化学合成方法

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB885516A (en) * 1958-01-16 1961-12-28 Arthur Henry Clarkson Higher fatty acid esters of dextran
US3325466A (en) 1961-01-11 1967-06-13 American Cyanamid Co Tertiary butyl group as a carboxyl protecting group in the synthesis of peptides
GB9005966D0 (en) 1990-03-16 1990-05-09 May & Baker Ltd New compositions of matter
JP3097143B2 (ja) 1991-02-21 2000-10-10 チッソ株式会社 生理活性物質合成用光学活性化合物の製造法および光学活性中間体化合物
CA2118796A1 (en) 1991-09-20 1993-04-01 John Crosby Pyranones
WO1993008823A1 (en) 1991-11-06 1993-05-13 Tanabe Seiyaku Co., Ltd. Guanidinyl and related cell adhesion modulation compounds
US5278313A (en) 1992-03-27 1994-01-11 E. R. Squibb & Sons, Inc. Process for the preparation of 1,3-dioxane derivatives useful in the preparation of HMG-COA reductase inhibitors
US5795749A (en) 1995-04-05 1998-08-18 The Scripps Research Institution Use of 2-deoxyribose-5-phosphate aldolase to prepare 2-deoxyfucose, analogues and derivatives
GB9523924D0 (en) 1995-11-23 1996-01-24 Zeneca Ltd Production of optically active 2-substituted tetrahydropyran-4-ones
FR2741620B1 (fr) 1995-11-28 1997-12-26 Oreal Procede de preparation de composes a groupement beta-hydroxy -delta-lactone analogues de la (+) compactine et de la (+) mevinoline
US6278001B1 (en) 1995-11-28 2001-08-21 L'oréal Method for preparing (+) compactin and (+) mevinolin analog compounds having a β-hydroxy-δ-lactone grouping
ES2207202T3 (es) 1998-04-30 2004-05-16 Kaneka Corporation Procedimiento para producir derivados de acido 6-cianometil-1, 3-dioxano-4-acetico.
EP1619191B1 (en) 1998-08-05 2010-10-27 Kaneka Corporation Process for producing optically active 2-[6-(hydroxymethyl)-1,3-dioxan-4-yl] acetic acid derivatives
EP1055671B1 (en) 1998-12-10 2004-12-01 Kaneka Corporation A process for producing a simvastatin precursor
GB9903472D0 (en) 1999-02-17 1999-04-07 Zeneca Ltd Chemical process
HU227840B1 (en) * 1999-05-06 2012-05-02 Egis Gyogyszergyar Nyilvanosan M Kod Ruszvunytarsasag Intermediates of atorvastatin synthesis and process for producing them
KR20010072175A (ko) 1999-06-04 2001-07-31 후루타 타케시 5-히드록시-3-옥소펜탄산 유도체 제조방법
AU2000254249A1 (en) 2000-03-28 2001-10-08 Biocon India Limited Synthesis of (r-(r*,r*))-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-
GB0011120D0 (en) 2000-05-09 2000-06-28 Avecia Ltd Process
NL1015744C2 (nl) * 2000-07-19 2002-01-22 Dsm Nv Werkwijze voor de bereiding van 2-(6-gesubstitueerde-1,3-dioxan-4-yl) azijnzuurderivaten.
AR034772A1 (es) 2001-07-13 2004-03-17 Astrazeneca Uk Ltd Preparacion de los compuestos de aminopirimidina
EP1323717A1 (en) 2001-12-27 2003-07-02 Dsm N.V. Process for the preparation of 2-(6-Substituted-1,3-Dioxane-4-yL) acetic acid derivatives
GB0218781D0 (en) 2002-08-13 2002-09-18 Astrazeneca Ab Chemical process
KR101060215B1 (ko) 2002-12-16 2011-08-29 아스트라제네카 유케이 리미티드 피리미딘 화합물의 제조 방법
GB0312896D0 (en) 2003-06-05 2003-07-09 Astrazeneca Ab Chemical process
WO2004113314A1 (en) 2003-06-23 2004-12-29 Biocon Limited Novel boronate esters
UY28501A1 (es) 2003-09-10 2005-04-29 Astrazeneca Uk Ltd Compuestos químicos
GB0321827D0 (en) 2003-09-18 2003-10-15 Astrazeneca Uk Ltd Chemical compounds
GB0324791D0 (en) 2003-10-24 2003-11-26 Astrazeneca Ab Chemical process
TWI276043B (en) 2004-09-09 2007-03-11 Seiko Epson Corp Display apparatus
GB0428328D0 (en) 2004-12-24 2005-02-02 Astrazeneca Uk Ltd Chemical process

Also Published As

Publication number Publication date
CA2490205A1 (en) 2003-12-24
DK1515962T3 (da) 2007-03-26
MXPA04012651A (es) 2005-08-15
IS7617A (is) 2004-12-28
SI1515962T1 (sl) 2007-04-30
AU2003277230A1 (en) 2003-12-31
EP1375493A1 (en) 2004-01-02
WO2003106447A1 (en) 2003-12-24
ZA200409986B (en) 2005-10-19
CN101812045A (zh) 2010-08-25
CA2490205C (en) 2011-04-19
NZ537260A (en) 2006-06-30
PL207130B1 (pl) 2010-11-30
ATE348825T1 (de) 2007-01-15
EP1515962B1 (en) 2006-12-20
NO20045491L (no) 2005-01-14
EP1515962A1 (en) 2005-03-23
JP2005533065A (ja) 2005-11-04
CY1107344T1 (el) 2012-12-19
KR20050042461A (ko) 2005-05-09
NO328946B1 (no) 2010-06-28
IL165767A0 (en) 2006-01-15
AU2003277230B2 (en) 2007-07-05
DE60310559T2 (de) 2007-12-27
RU2004139042A (ru) 2005-08-10
CN1662520A (zh) 2005-08-31
CN1662520B (zh) 2010-08-11
US20060122407A1 (en) 2006-06-08
KR101008920B1 (ko) 2011-01-17
HK1073303A1 (en) 2005-09-30
DE60310559D1 (de) 2007-02-01
EG24561A (en) 2009-10-25
PL375077A1 (en) 2005-11-14
UA79970C2 (en) 2007-08-10
JP4632784B2 (ja) 2011-02-16
US7442811B2 (en) 2008-10-28
ES2278174T3 (es) 2007-08-01
CN101812045B (zh) 2012-07-18
RU2315761C2 (ru) 2008-01-27
PT1515962E (pt) 2007-02-28
BR0311884A (pt) 2005-04-05

Similar Documents

Publication Publication Date Title
CY1107344T1 (el) Διαδικασια για την παρασκευη εστερων οξικου οξεος διοξανιου
HK1097260A1 (en) Intermediates for the preparation of 2-(6-substituted-1,3-dioxane-4-yl) acetic acid derivatives
KR910021366A (ko) 4-(4-알콕시페닐)-2-부틸아민 유도체 및 그의 제조방법
ATE36517T1 (de) Optisch aktive alpha-substituierte arylketone, verfahren zu ihrer herstellung und ihre anwendung in der herstellung von alphaarylalkancarbons|uren.
ATE409693T1 (de) Verfahren zur herstellung von 2-(4- chlorbenzoylamino-3- 2(1h)-chinolinon-4-yl propionsäure
ATE509914T1 (de) Verfahren zur herstellung optisch aktiver oxoheptensäureester
KR960031442A (ko) 페닐시클로헥실카르복스아미드의 용도
EP0401704A3 (en) Process for the preparation of organic esters
FI881959A (fi) Karboksyylihappoestereiden pelkistys
EP1378502A4 (en) OLIGOLACTIC ACID ESTER WITH CHAIN
DE69937988D1 (de) Verfahren zur herstellung von 3-cephemderivaten
EA200600496A1 (ru) Способ получения оптически чистых производных 2-(4-гидроксифенокси)пропионовой кислоты
ATE286870T1 (de) Verfahren zur herstellung von estern
PL326563A1 (en) Method of obtaining derivatives of methoxyiminophenyglyoxalic acid
DE60026407D1 (de) Verfahren zur Herstellung von Vitamin-D Analogen
ATE425132T1 (de) Neues verfahren zur stereoselektiven reduktion von beta-ketoestern
UST103205I4 (en) Intermediates and process for insecticidal 4-phenyl-2-indanyl esters
MXPA02005084A (es) Procedimiento para fabricar tienopirimidinas.
DE69906009T2 (de) Verfahren zur Herstellung von 2-Alkyliden-4-Bromacetessigsäureestern
KR950014081A (ko) 2-(4,6-디메톡시피리미딘-2-일)옥시아세토페논유도체, 그의 제조방법 및 제초제로서 그의 용도